4D Molecular Therapeutics, Inc. (FDMT) Net Income by Year
4D Molecular Therapeutics, Inc. reported a net loss of $140.1M in fiscal year 2025. This represents an increase of 12.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to a $179.2M net loss. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters 4D Molecular Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FDMT Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
FDMT Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More 4D Molecular Therapeutics, Inc. financials
Frequently Asked Questions
What was 4D Molecular Therapeutics, Inc.'s net income in fiscal year 2025?
4D Molecular Therapeutics, Inc. reported a net loss of $140.1M in fiscal year 2025.
How fast is 4D Molecular Therapeutics, Inc.'s net income growing?
4D Molecular Therapeutics, Inc. (FDMT) net income rose by 12.9% year over year, from -$160.9M to -$140.1M in fiscal year 2025.
What is 4D Molecular Therapeutics, Inc.'s net income over the last twelve months?
4D Molecular Therapeutics, Inc. (FDMT) reported a $179.2M net loss over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has 4D Molecular Therapeutics, Inc.'s net income changed over the years?
Across the 7 fiscal years this page covers, 4D Molecular Therapeutics, Inc. (FDMT) net income went from -$49.3M in fiscal year 2019 to -$140.1M in fiscal year 2025.
What was 4D Molecular Therapeutics, Inc.'s net income in the most recent quarter?
4D Molecular Therapeutics, Inc. (FDMT) reported -$72.9M in net income in Q2 2026. This represents a decrease of 33.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what 4D Molecular Therapeutics, Inc. (FDMT) reported on that line in every period on record.